Search results
Researchers take step toward development of universal COVID-19 antibodies
KTBS Shreveport· 19 hours agoSARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 hours agoCoupled with Invivyd’s proprietary mAb technology platform and engineering capabilities, this pathway provides the company with the opportunity to rapidly, efficiently, and durably deliver high ...
Jacksonville research group seeks participants for new COVID-19 vaccine trial
WJXT Jacksonville· 2 days agoResearchers at the Jacksonville Center for Clinical Research (JCCR) are recruiting people to...
Levels of COVID in Mass. wastewater tick up with arrival of new ‘FLiRT’ variants - The Boston Globe
The Boston Globe· 2 days agoDoron called the increase “very, very, very gradual.” “Certainly it’s nothing like when Omicron was...
After grilling an NIH scientist over COVID emails, Congress turns to Anthony Fauci
St. Louis Post-Dispatch· 4 hours agoFormer National Institutes of Health official Anthony Fauci has faced many hostile questions from...
‘No reason to panic’ in Singapore, even with latest wave of Covid-19 infections
South China Morning Post· 6 days agoSince news about the rise in the number of cases broke, many pharmacies have seen Covid-19 test kits...
Ignore the disinformation — the US is safer with a global pandemic treaty
The Hill· 1 day agoThis week, World Health Organization (WHO) member states meeting at the World Health Assembly are...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 7 days ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing ...
New COVID variants are spreading in California. How worried should we be?
Los Angeles Times· 2 days agoThe latest data show that those subvariants are the dominant COVID family in the U.S., jumping from about 20% of infections a month ago to more than 50%. “COVID-19& ...
US Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
Forbes· 1 day agoCiting unnamed people close to the discussion, the Financial Times reported federal funding worth...